Morpho (MORPHO) is currently priced at $1.33, reflecting a 24-hour decline of 1.49%. The daily range has been minimal, with a high of $1.36 and a low of $1.32, indicating low volatility in the short term.

Volume over the last 24 hours stands at approximately 5.69 million, representing 0.79% of the market cap, suggesting moderate trading activity. The short-term moving averages (8 SMA at $1.33, 13 SMA at $1.33) indicate bearish momentum, as they are trending downwards, with the 55 SMA showing a more significant decline at -2.50%.

The 1-hour RSI of 36 suggests that Morpho is currently oversold, which could lead to a potential price correction in the short term. In contrast, the 7-day RSI of 53 indicates a neutral stance, reflecting a broader stability in the medium-term price action.

From a performance perspective, Morpho has experienced a 2.61% increase over the past week, and a notable 17.50% rise over the last 14 days, indicating a positive momentum shift. The 30-day price change of 15.80% further reinforces this uptrend, suggesting that recent market sentiment has been bullish.

However, despite the encouraging longer-term performance, the recent price action and short-term indicators suggest caution. The current price is significantly below the all-time high of $4.17, attained in January 2025, indicating that Morpho still has considerable room for growth.

Considering the current oversold conditions combined with the positive longer-term trends, a Buy rating is appropriate. Investors may find a favorable entry point here, but should remain aware of short-term volatility risks.